Your browser doesn't support javascript.
loading
TCB2, a new anti-human interleukin-2 antibody, facilitates heterodimeric IL-2 receptor signaling and improves anti-tumor immunity.
Lee, Jun-Young; Lee, Eunjin; Hong, Sung-Wook; Kim, Daeun; Eunju, O; Sprent, Jonathan; Im, Sin-Hyeog; Lee, You Jeong; Surh, Charles D.
Afiliación
  • Lee JY; Academy of Immunology and Microbiology, Institute for Basic Science (IBS), Pohang, Republic of Korea.
  • Lee E; Division of Integrative Biosciences & Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.
  • Hong SW; Division of Integrative Biosciences & Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.
  • Kim D; Academy of Immunology and Microbiology, Institute for Basic Science (IBS), Pohang, Republic of Korea.
  • Eunju O; Academy of Immunology and Microbiology, Institute for Basic Science (IBS), Pohang, Republic of Korea.
  • Sprent J; Division of Integrative Biosciences & Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.
  • Im SH; Academy of Immunology and Microbiology, Institute for Basic Science (IBS), Pohang, Republic of Korea.
  • Lee YJ; Division of Integrative Biosciences & Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.
  • Surh CD; Department of Immunology, Garvan Institute of Medical Research, Darlinghurst, Australia.
Oncoimmunology ; 9(1): 1681869, 2020.
Article en En | MEDLINE | ID: mdl-32002288

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Interleucina-2 / Interleucina-2 / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales / Neoplasias Experimentales Límite: Animals / Humans Idioma: En Revista: Oncoimmunology Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Interleucina-2 / Interleucina-2 / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales / Neoplasias Experimentales Límite: Animals / Humans Idioma: En Revista: Oncoimmunology Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos